Aclaris Therapeutics, Inc.
ACRS
$6.18
$0.162.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.27% | 0.10% | -20.11% | -24.91% | -10.16% |
| Total Receivables | 3,100.52% | 1,825.60% | -54.96% | 1,264.43% | -40.31% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -32.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -6.18% | 1.32% | -23.53% | -23.98% | -11.42% |
|
|
|||||
| Total Current Assets | -6.18% | 1.32% | -23.53% | -23.98% | -11.42% |
| Net Property, Plant & Equipment | -22.87% | -20.88% | -20.88% | -21.13% | -21.82% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -50.00% | -47.97% | 116.96% | 67.08% | 61.83% |
| Total Assets | -5.00% | 0.32% | -27.17% | -3.76% | 17.43% |
|
|
|||||
| Total Accounts Payable | 76.38% | 131.84% | 180.55% | 19.90% | 21.02% |
| Total Accrued Expenses | -5.38% | -0.96% | -4.47% | 85.84% | 42.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.17% | 14.26% | 14.55% | 14.62% | 14.70% |
| Total Finance Division Other Current Liabilities | -40.45% | -25.27% | -59.70% | 33.50% | 177.99% |
| Total Other Current Liabilities | -40.45% | -25.27% | -59.70% | 33.50% | 177.99% |
| Total Current Liabilities | 5.22% | 27.22% | -9.34% | 36.22% | 71.15% |
|
|
|||||
| Total Current Liabilities | 5.22% | 27.22% | -9.34% | 36.22% | 71.15% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -31.82% | -28.70% | -26.07% | -23.79% | -21.80% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -10.83% | -13.90% | -12.53% | -9.91% | 212.15% |
| Total Liabilities | -4.00% | 1.93% | -11.42% | 6.11% | 110.68% |
|
|
|||||
| Common Stock & APIC | 6.52% | 6.56% | 1.13% | 14.04% | 14.11% |
| Retained Earnings | -8.11% | -7.59% | -7.19% | -17.57% | -16.86% |
| Treasury Stock & Other | -163.07% | -94.93% | 528.87% | 39.81% | 204.10% |
| Total Common Equity | -5.43% | -0.29% | -33.73% | -7.72% | -1.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.43% | -0.29% | -33.73% | -7.72% | -1.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.43% | -0.29% | -33.73% | -7.72% | -1.56% |
|
|
|||||